TUESDAY, June 25, 2024 (HealthDay News) — A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests. Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compared to a placebo, researchersContinue Reading

TUESDAY, June 25, 2024 (HealthDay News) — As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday. In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states andContinue Reading

TUESDAY, June 25, 2024 (HealthDay News) — For decades, millions of Americans popped a low-dose aspirin each day to lower their heart risks. Then, accumulated data prompted the nation’s two leading cardiology groups — the American College of Cardiology and the American Heart Association — to overturn advisories in 2019Continue Reading

MONDAY, June 24, 2024 (HealthDay News) — The U.S. Food and Drug Administration’s decision to authorize the first menthol-flavored e-cigarettes has drawn the the ire of health advocates who say the decision undermines efforts to end the youth vaping epidemic in America. In its approval of four flavored vaping productsContinue Reading

WEDNESDAY, June 19, 2024 (HealthDay News) — Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with opioid use disorder involves drugs like buprenorphine, methadone and naltrexone, which help suppress cravings and blunt the effectsContinue Reading